Portea medical, one in every of India’s greatest systems for home healthcare visits, has raised $ 26 million in series C funding to extend its provider range. The round changed into led by using Sabre partners and MEMG CDC, with participation from returning investors Accel (which led Portea’s series B two years in the past), the area bank group’s overseas Finance agency and Qualcomm Ventures.
Portea has now raised a total of about $ 72.5 million. In a press commentary, Sabre partners founder and managing partner Rajiv Maliwal said Portea clinical “has played a key position in setting up the idea of purchaser-led healthcare and we seem ahead to working with them as they continue to transform healthcare functions in India past the health center area.”
The demand for domestic healthcare is becoming right away in India, because of components like an getting old population and social changes that skill fewer working-age adults are in a position to function full-time caretakers for elderly relatives. a few of Portea medical’s leading opponents consist of Nightingales domestic fitness functions, Healthcare At home and Care24.
one among Portea’s specialities is an eldercare plan it really is billed yearly, when you consider that assisted living communities are a relatively new concept in India. on account that its launch, it’s elevated its core offerings into three different segments: primary care, persistent sickness management and post-operative care.
Portea partners with healthcare suppliers, including 50 hospitals, to permit domestic visits for patients who might have quandary traveling for checkups, like the aged or bodily disabled, or just wish to keep away from overcrowded hospitals. Its other products consist of lab checks where samples are taken at domestic and picked up by using considered one of Portea’s couriers and B2B services for companies that want to deliver personnel with on-website vaccination classes or health screenings. Portea claims that it has served 250,000 valued clientele in 16 cities to this point.
Fundings & Exits – TechCrunch